SCHEMBL7788360

SCHEMBL7788360

N=C(N)Nc1cccc(S(=O)(=O)Nc2cccc(C(CC(=O)O)NC(=O)c3ccc(OC(F)(F)F)cc3)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MMP12 P39900 2/20 0.44
ITGB3 P05106 2/20 0.43
ITGAV P06756 1/20 0.43
ITGA2B P08514 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
AURKA O14965 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7781187 0.90 GAA (0.47) LMNAITGB3ITGA2B
SCHEMBL7785662 0.90 MAPT (0.48) LMNASMN1; SMN2ITGB3ITGA2BRAB9A
SCHEMBL7790184 0.88 MEN1 (0.48) LMNASMN1; SMN2ITGB3ITGAVITGA2B
SCHEMBL7194908 0.88 ITGB3 (0.51) LMNASMN1; SMN2ITGB3ITGAVITGA2B
SCHEMBL7789975 0.87 ITGB3 (0.46) LMNAITGB3ITGAVITGA2B
SCHEMBL7781212 0.87 ITGB3 (0.48) ITGB3ITGAVITGA2B
SCHEMBL7788754 0.85 ITGB3 (0.51) ITGB3ITGAVITGA2B
SCHEMBL7785609 0.85 LMNA (0.45) LMNASMN1; SMN2ITGB3ITGA2B
SCHEMBL7786217 0.84 KMT2A (0.46) LMNASMN1; SMN2ITGB3ITGAVITGA2B
SCHEMBL7786246 0.83 ITGB3 (0.46) LMNASMN1; SMN2ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed